Synaptogenix Inc (SNPX)

[InTheTrenches]

Do you think Jenni Spencer, one of NTRP's compassionate-use patients, would have benefited from more sleep? Absolutely not. She was nearly comotose. Bryostatin was the difference in her improvements.

----

Here's a great idea: why don't we take a few of these moderate-to-severe Alzheimer's patients who have ~5 years to live, and put them in an induced coma for a year. Far more sleep than the average Alzheimer's patient.

Then we'll follow those patients for the remaining 4 years and see if this repairs their BBB and their synapses such that they survive beyond the 4 remaining years.

Finally, this should be a placebo-controlled, double-blind study. Wouldn't want to get potentially false signals, like trials run by other Alzheimer's companies, who claim success based on uncontrolled, unblinded studies.